Concepedia
Statistics
Publications
7
Citations
401
H-Index
Active since
2006
Affiliations
Chi Mei Medical Center(Current)
Southern Taiwan University of Science and Technology
National Cheng Kung University
Kaohsiung Medical University
Chang Gung University
Hao-Hsien Lee is an author at Chi Mei Medical Center specializing in molecular oncology, medicine, and oncology.
Publications per year
2006–2017
miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer
Hao‐Yi Li, Jui-Lin Liang, Yao-Lung Kuo et al. · Breast Cancer Research · 2017 · 171 citations · Full text
Medicine, Cancer Biology, Oncology +17
Cantharidin-induced cytotoxicity and cyclooxygenase 2 expression in human bladder carcinoma cell line
Steven Kuan-Hua Huan, Hao-Hsien Lee, Der-Zen Liu et al. · Toxicology · 2006 · 71 citations
Medicine, Oncology, Pharmacology +11
p53 and p27 as predictors of clinical outcome for rectal-cancer patients receiving neoadjuvant therapy
Li-Ching Lin, Hao-Hsien Lee, Wei-Shou Hwang et al. · Surgical Oncology · 2006 · 46 citations
Medicine, Oncology, Surgery +15
SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential
Yu-Feng Tian, Tzu-Ju Chen, Ching-Yih Lin et al. · Tumor Biology · 2013 · 44 citations
Medicine, Oncology, Pharmacology +17
Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy
Chien‐Feng Li, Hong-Lin He, Jaw‐Yuan Wang et al. · Journal of Clinical Pathology · 2014 · 26 citations
1–5 of 7